Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Surgery ; (12): 1610-1615, 2009.
Article in Chinese | WPRIM | ID: wpr-291047

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the early results of precise liver resection.</p><p><b>METHODS</b>Between May 2006 and June 2009, 65 patients with complicated liver space-occupying lesions were included in the study. Fifty-one patients underwent curative liver resection. Liver resections performed included 16 trisectionectomies, 11 hemihepatectomy, 5 meso hepatectomies, 3 combined segmentectomies, 5 caudate lobectomies and 11 irregular local resections.</p><p><b>RESULTS</b>Patients undergoing resection had no mortality with a major morbidity of 9.8%. Nineteen vascular repairs and reconstructions were patent at last follow-up. The postoperative 1-year survival rate was 100% in 10 patients with benign lesions and 92.7% in 41 patients with malignant tumors. The 1-year survival rate was zero in patients with malignant tumors, who underwent no liver resection.</p><p><b>CONCLUSIONS</b>Precise liver resection, as an aggressive surgical approach, offers hope for these patients, who would otherwise have a dismal prognosis.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Hepatectomy , Methods , Liver , General Surgery , Liver Diseases , General Surgery , Prognosis , Retrospective Studies
2.
Chinese Journal of Oncology ; (12): 39-42, 2006.
Article in Chinese | WPRIM | ID: wpr-308426

ABSTRACT

<p><b>OBJECTIVE</b>To study the influence of percutaneous microwave ablation (PMA) and surgical resection for patients with small primary hepatocellular carcinoma (PHC) on dissemination of tumor cells in peripheral blood determined by AFP mRNA.</p><p><b>METHODS</b>Forty patients with small PHC (The maximal diameter < or = 5 cm) confirmed histologically were included in this study. All the patients had single tumor nodule only without metastasis. Of the 40 patients, 19 were treated by PMA and 21 by surgical resection. Blood samples were collected and tested immediately before treatment, 30 min after the mass ablated/resected, 1 d and 7 d later by RTD-Nested-RT-PCR for AFP mRNA. The CD3, CD4, CD8 and CD4/CD8 in blood, and hepatic function were tested at the same time points as well.</p><p><b>RESULTS</b>After treatment, ALT and AST in peripheral blood increased in both groups, but more intensely in the surgical group. The CD3, CD4 and CD4/CD8 in peripheral blood decreased at 30 min, 1 day and 7 days after surgical resection, and the lowest value was at 30 min after surgery. The immune function was kept at the same level as pre-treatment in the PMA group. AFP mRNA copies in blood could be detected in 27 of 40 patients (67.5%) in two groups before treatment, and the copy number was increased after treatment. There was no significant difference between the two groups. The patients were followed up for 1 - 16 months. AFP mRNA copies in blood could be detected persistently in the 4 patients with extrahepatic metastasis or liver recurrence.</p><p><b>CONCLUSION</b>Surgical resection and microwave ablation may cause PHC cells dissemination into the blood circulation in patients with small PHC, and there was no difference between the two treatment groups. The cellular immune function in peripheral blood is decreased after surgical resection, but is maintained at the same level as pre-treatment in the PMA group. The impairment of liver function is less severe after PMA treatment than surgical resection. PMA may provide certain value for clinical management of small hepatocellular carcinoma.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , CD3 Complex , Blood , CD4 Antigens , Blood , CD4-CD8 Ratio , CD8 Antigens , Blood , Carcinoma, Hepatocellular , Blood , General Surgery , Therapeutics , Catheter Ablation , Methods , Follow-Up Studies , Hepatectomy , Liver Neoplasms , Blood , General Surgery , Therapeutics , Microwaves , Therapeutic Uses , Neoplasm Recurrence, Local , RNA, Messenger , Genetics , alpha-Fetoproteins , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL